Group 1 - The stock price of Jibeier has dropped by 5.08% on September 23, reaching 34.20 CNY per share, with a trading volume of 81.19 million CNY and a turnover rate of 1.16%, resulting in a total market capitalization of 6.821 billion CNY. The stock has experienced a continuous decline for six days, with a cumulative drop of 6.29% during this period [1] - Jibeier Pharmaceutical Co., Ltd. is located in the High-tech Industrial Development Zone of Zhenjiang, Jiangsu Province, established on November 13, 2001, and listed on May 18, 2020. The company's main business involves drug research and development, production, and sales. The revenue composition is as follows: Likujun tablets 72.72%, Nigulol tablets 14.20%, Yipingfeng capsules 4.88%, others 4.53%, and Acetylsalicylic acid enteric-coated tablets 3.67% [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under GF Fund holds Jibeier as a significant investment. The GF Stable Growth Mixed A Fund (002622) held 10,500 shares in the second quarter, accounting for 0.51% of the fund's net value, making it the third-largest heavy stock. The estimated floating loss today is approximately 19,300 CNY, with a total floating loss of 25,500 CNY during the six-day decline [2] - The GF Stable Growth Mixed A Fund (002622) was established on June 27, 2016, with a latest scale of 55.5805 million CNY. Year-to-date return is 4.32%, ranking 6825 out of 8172 in its category; the one-year return is 6.46%, ranking 7353 out of 7995; and the return since inception is 36.36% [2]
吉贝尔股价跌5.08%,广发基金旗下1只基金重仓,持有1.05万股浮亏损失1.93万元